Evidence map›Paper›PMID 42215990›Full record

ArticleCell communication and signaling : CCS2026

Mast cells release DNA Extracellular Traps (DETs) in response to SARS-CoV-2 and its spike protein.

Bruna Carlos-Nascimento, Gean C Pereira-Silva, Jairo R Temerozo, Sharton Vinicius Antunes Coelho, Luciana B Arruda, Jorge Mansur Medina, Teresa Calegari-Silva, Ulisses Gazos Lopes, Camila Couto Espírito-Santo, Natalia C Rochael and 11 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Bruna Carlos-NascimentoLaboratory of Innate Immunity, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Gean C Pereira-SilvaLaboratory of Innate Immunity, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Jairo R TemerozoLaboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, RJ, Brazil.
Sharton Vinicius Antunes CoelhoLaboratório de Genética e Imunologia das Infecções Virais, Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Luciana B ArrudaLaboratório de Genética e Imunologia das Infecções Virais, Departamento de Virologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Jorge Mansur MedinaLaboratório de Estrutura e Regulação de Proteínas e ATPases, Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
Teresa Calegari-SilvaLaboratório de Parasitologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil.
Ulisses Gazos LopesLaboratório de Parasitologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil.
Camila Couto Espírito-SantoLaboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, RJ, Brazil.
Natalia C RochaelLaboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, RJ, Brazil.
Phillipe de Souza Lima-GomesLaboratory of Innate Immunity, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Marisa DolhnikoffLaboratório de Patologia Ambiental e Experimental, Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Thais MauadLaboratório de Patologia Ambiental e Experimental, Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Beatriz Carvalho-LimaLaboratório de Inflamação, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Willian A GomesLaboratório de Inflamação, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Bruno L DiazLaboratório de Inflamação, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Paola Oliveira LopesNúcleo de Doenças Infecciosas e Núcleo de Biotecnologia, Universidade Federal do Espírito Santo, Vitoria, ES, Brazil.
Luciana Polaco CovreNúcleo de Doenças Infecciosas e Núcleo de Biotecnologia, Universidade Federal do Espírito Santo, Vitoria, ES, Brazil.
Daniel Cláudio Oliveira GomesNúcleo de Doenças Infecciosas e Núcleo de Biotecnologia, Universidade Federal do Espírito Santo, Vitoria, ES, Brazil.
Dumith Chequer Bou-HabibLaboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, RJ, Brazil.
Elvira M SaraivaLaboratory of Innate Immunity, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. esaraiva@micro.ufrj.br.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 310670/2021-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 311204/2021-0Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/200.960/2021Fundação Carlos Chagas Filho de Apoio à Pesquisa do Estado do Rio de Janeiro E-26/201.136/2021Oswaldo Cruz Foundation (INOVA Program) 48400295262517The Mercosur Structural Convergence Fund (FOCEM, Mercosur) 03/11
6 · The paper itself

Abstract

backgroundInfection by SARS-CoV-2 is associated with an uncontrolled and damaging inflammatory response during severe COVID-19 disease, during which immune cells, such as neutrophils, monocytes, and macrophages, release pro-inflammatory mediators leading to the development of acute respiratory distress syndrome. Mast cells may also contribute to the pathogenesis of COVID-19, as increased serum levels of their proteases are associated with the severity of the disease. Mast cells are strategically located in tissues that interface with the external environment, such as the skin, respiratory tract, and gastrointestinal mucosa, exhibiting microbicidal activities, including phagocytosis and the release of DNA embedded with granular proteins, known as DNA extracellular traps (DETs). METHODS AND

resultsWe show that the inactivated SARS-CoV-2 virions and the SARS-CoV-2 recombinant Spike protein induce DET formation in the human mast cell line HMC-1, with participation of TLR2 and TLR4 recognition. Using pharmacological inhibitors, we demonstrate the involvement of reactive oxygen species (ROS), NF-кB, peptidyl arginine deiminase (PAD), calcium, and serine proteases in the formation of DETs by either stimulus. DETs were toxic to pulmonary epithelial and endothelial cells, with tryptase, H3 citrullinated histone, and DNA scaffold contributing to cytotoxicity by apoptosis. Exposure of infectious virions to DETs reduced SARS-CoV-2 infection in Calu-3 cells, suggesting that the viral particles were trapped and killed by DETs. Furthermore, we also detected DET structures, characterized by colocalization of tryptase, citrullinated histone H3, and DNA, in the lung biopsies of COVID-19 patients.

conclusionTaken together, our results suggest a dual role for mast cell DETs during SARS-CoV-2 infection, as they damage both pulmonary epithelial and endothelial cells while capturing SARS-CoV-2 virions and inhibiting viral infection. Our findings are consistent with the assumption that mast cell DETs control the viral load by reducing SARS-CoV-2 infectivity.

Indexed as

COVID-19Extracellular TrapsMast CellsSARS-CoV-2Spike Glycoprotein, CoronavirusCell LineExtrachromosomal DNAHumansReactive Oxygen SpeciesExtrachromosomal DNAReactive Oxygen SpeciesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19DNA Extracellular traps (DETs)Mast cellsSARS-CoV-2Spike protein

Identifiers

PMID42215990
PMCPMC13418154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.